atherothrombotic

ath·er·o·throm·bot·ic

(ath'er-ō-throm-bot'ik),
Denoting, characteristic of, or caused by atherothrombosis.
References in periodicals archive ?
The subject of the contract is a special medical material - a catheter for endovascular mechanical thrombectomy of acute, Subacute and chronic thrombotic or atherothrombotic occlusions in arterial and venous blood vessels capable of treating nave vessels, In stent closures, Bypass closures and dialysis fistules.
Association between inflammation and hemostatic markers in atherothrombotic stroke.
It lacked follow-up, hence predictive value of low ABI in terms of future risk of atherothrombotic events such as recurrent stroke, angina, myocardial infarction, death or disability is not known.
We performed a nested prospective biomarker substudy within the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2P)-Thrombolysis in Myocardial Infarction (TIMI) 50 trial (TRA 2[degrees]P - TIMI 50) (14).
In acute coronary syndromes, unstable atherothrombotic plaques contain more lipids and thrombi and less calcification.
The trial evaluated the treatment of Brilinta 90mg tablets twice daily compared with clopidogrel 75mg once daily for the prevention of atherothrombotic events (a composite of cardiovascular death, heart attack or ischaemic stroke).
An increasing body of evidence has linked inflammation with the pathogenesis of atherothrombotic stroke.
Atherothrombotic risk factors and premature coronary heart disease in India: A case control study.
He pointed out that we cannot prevent IHD which is an atherosclerosis process which starts much early in adult life but we can reduce the atherothrombotic events with the use of Aspirin.
Atherothrombotic infarct occurs due to occlusion caused by thrombus formation on arterial walls or thrombus separation from arterial walls such as in the internal carotid and middle cerebral arteries.
Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity.
Predictors of healthcare use among patients with or at high risk of atherothrombotic disease: two-year follow-up data.